NetworkNewsBreaks Archive - Page 250 of 1739

WednesdayJan 25, 2023 10:57 am

NetworkNewsBreaks – DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) to Host Q4 and FY 2022 Earnings Call

DoubleDown Interactive (NASDAQ: DDI), a leading gaming company delivering unique player experiences across a variety of genres, today announced that it will hold a conference call at 5:00 p.m. Eastern Time on Tuesday, Feb. 7, 2023, to discuss its results for the fourth quarter and full year ended Dec. 31, 2022. DoubleDown management will host a presentation followed by a question-and-answer period. Interested parties should visit https://nnw.fm/qmkW9 to register for the call, after which they will be sent dial-in details and a unique access code. Attendees are asked to register a minimum of 15 minutes prior to the start of…

WednesdayJan 25, 2023 10:27 am

NetworkNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) $4.1M Placements Supported by Aegis Capital Corp. as Exclusive Placement Agent

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, recently announced the closing of both a registered direct and a private placement; the placements totaled approximately $4.1 million. Aegis Capital Corp. acted as exclusive placement agent for those placements. In the wealth management and investment banking business since 1984, Aegis has built a reputation for offering corporate finance and strategic advisory services to public and private companies across multiple sectors and regions. In addition, the company offers expert research and sales and trading services to institutional investors. Aegis provides a conflict-free service platform as well as…

TuesdayJan 24, 2023 11:58 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses ‘Lifeblood’ of Phase 2 Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biopharmaceutical company focused on developing novel treatments for primary and metastatic cancers in the brain and central nervous system, is enrolling patients in a phase 2 trial to evaluate the efficacy of its flagship drug candidate. The potentially pivotal trial will evaluate Berubicin for the treatment of glioblastoma multiforme (“GBM”), an aggressive brain tumor with an average overall survival rate of only 10-12 months. The company’s Chief Executive Officer John Climaco recently participated in the Virtual Investor “Ask the CEO” Event and discussed that enrollment in the trial was approaching 70 patients against a…

TuesdayJan 24, 2023 11:33 am

NetworkNewsBreaks – MetAlert Inc. (MLRT) Approaching Inflection Point of Its Growth Curve

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, is launching a suite of wearable companion products to its innovative SmartSole shoe insole units. “The patented GPS-enabled SmartSole is a non-intrusive tracking device designed to monitor the location of people with cognitive memory disorders such as Alzheimer’s Disease who tend to get lost or wander. The tech-designed insole may also be used by people at risk of kidnapping, such as children, government employees and select professionals. A next-generation shoe insole branded SmartSole plus incorporates biometric sensors paired with smart analytics to…

TuesdayJan 24, 2023 11:08 am

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Working Toward Global Leadership in CBD Space

Flora (NASDAQ: FLGC) has transitioned from the development stage to a full-scale international distributor with operations in over 12 countries worldwide, achieved under Luis Merchan’s tenure as CEO. “Merchan has also spearheaded several mergers and acquisitions, most notably JustCBD and Vessel Brand, which have since set the company up for rapid growth. Flora also secured $34.5 million in financing and signed deals with key retail distributors such as Tropi, a Colombia-based distributor, Walmart and Macy’s. The company also completed its first import of CBD-containing food and beverage products into the United States from Colombia under its Mambe brand. It has…

TuesdayJan 24, 2023 10:56 am

NetworkNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Senior Medical Tech Veteran as New President

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, has appointed Robert Eno to the newly created position of president. A senior medical technology executive, Eno will work to enhance the company’s strategic and operations capabilities. Eno brings a background of almost three decades experience in developing markets and commercializing disruptive medical technologies to his new role, where he will be essential in the company’s strategic direction, commercialization efforts, and day-to-day operations. Eno noted that he believes HeartBeam’s technology will be able to make a…

TuesdayJan 24, 2023 10:32 am

NetworkNewsBreaks – CubCrafters Inc. Has Changed the Face of Backcountry Aviation

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, is guided by superior quality, industry-leading innovation and independent thinking. “CubCrafters has changed the face of backcountry aviation by producing and selling seven innovative models of light aircraft. Segmented into three categories – Light Sport Aircraft (‘LSA’), Experimental Builder Assist (‘E/AB’), and Part 23 certified aircraft – the models include the Carbon Cub SS, Carbon Cub FX-2, Carbon Cub FX-3, Carbon Cub EX-2, Carbon Cub EX-3, NXCub, and XCub,” reads a recent article. In 2022, the company achieved several milestones including welcoming outside investment for…

TuesdayJan 24, 2023 10:07 am

NetworkNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Closes on $4.1M Direct, Private Placement Offerings

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair, skin and sexual wellness, has closed on its previously announced registered direct offering and concurrent private placement. The offering includes the purchase and sale of 4,315,787 shares in a registered direct offering, with the concurrent private placement calling for JUPW to issue and sell a total of 8,631,574 warrants to the same investors. The warrants are to purchase up to one share of common stock each at an exercise price of $1 per share. According to the announcement, the private placement warrants will be exercisable six months after issuance. The…

MondayJan 23, 2023 2:37 pm

NetworkNewsBreaks – Finovate VP Featured in Recent Episode of The Bell2Bell Podcast Event

Finovate host and vice president of strategy Greg Palmer is spotlighted in the latest release from the Bell2Bell Podcast. The announcement comes from IBN, a multifaceted communications organization engaged in connecting public companies to the investment community. During the interview, Palmer and IBN host Jonathan Keim talked about the impact of the pandemic on the fintech space and how the pandemic continues to drive innovation. Calling the pandemic a “reset point,” Palmer noted that the space is seeing more early-stage companies and an increase desire by venture capitalists to engage with those early-stage companies. He observed that during the next…

MondayJan 23, 2023 1:27 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Pharmaceutical Expert as New Strategic Advisor

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has a new strategic advisor. The company announced that Julian Gangolli, the former president of GW Pharmaceuticals USA, has joined Lexaria as a strategic advisor. During his time at GW Pharmaceuticals, Gangolli managed US Food and Drug Administration approval of Epidiolex(R), the only pure cannabidiol (“CBD”) drug ever approved by the agency; he also oversaw the commercialization of the drug in the United States, which ultimately led to Jazz Pharmaceuticals acquiring GW Pharmaceuticals in a $7.2 billion transaction. In addition to his work at GW Pharmaceuticals, Gangolli served as North…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks